|
|
|
Name
|
Market Cap
|
Revenue
|
Ratio
|
Beta
|
EPS
|
Dividend
|
Next Earnings Date
|
|---|---|---|---|---|---|---|---|---|---|
| ACADIA | 3.08B | 517.23M | -14.08 | 0.581 | -1.34 | - | May 03, 2023 | ||
| Agios Pharm | 1.28B | 14.24M | -5.50 | 0.916 | -4.23 | - | May 04, 2023 | ||
| Alkermes Plc | 4.59B | 1.11B | -28.09 | 0.586 | -0.968 | - | Apr 27, 2023 | ||
| Alnylam | 24.32B | 1.04B | -20.99 | 0.474 | -9.30 | - | Apr 27, 2023 | ||
| Amgen | 128.7B | 26.32B | 19.77 | 0.634 | 12.18 | 8.52 (3.63%) | Apr 25, 2023 | ||
| Bio-Techne | 11.33B | 1.12B | 43.18 | 1.21 | 1.67 | 0.32 (0.44%) | May 02, 2023 | ||
| BioNTech | 29.64B | 17.31B | 3.00 | 0.241 | 38.78 | 1.5498 (1.26%) | May 08, 2023 | ||
| Biogen | 39.59B | 10.17B | 13.04 | 0.193 | 20.97 | - | Apr 26, 2023 | ||
| Biomarin Pharma | 17.57B | 2.10B | 123.18 | 0.389 | 0.764 | - | Apr 26, 2023 | ||
| Charles River Laboratories | 10.07B | 3.98B | 20.57 | 1.36 | 9.57 | - | May 03, 2023 | ||
| EXACT Sciences | 11.96B | 2.08B | -19.05 | 1.42 | -3.54 | - | Apr 25, 2023 | ||
| Exelixis | 6.22B | 1.61B | 33.88 | 0.719 | 0.567 | - | May 03, 2023 | ||
| FibroGen Inc | 1.83B | 140.75M | -6.14 | 0.855 | -3.14 | - | May 11, 2023 | ||
| Genmab AS | 24.58B | 2.21B | 30.55 | 0.665 | 84.45 | - | May 10, 2023 | ||
| Gilead | 101.52B | 27.28B | 22.25 | 0.411 | 3.66 | 3 (3.88%) | May 04, 2023 | ||
| Grifols ADR | 4.82B | 6.06B | 21.29 | 0.449 | 0.306 | - (6.01%) | May 04, 2023 | ||
| IQVIA Holdings | 35.83B | 14.41B | 33.19 | 1.41 | 5.82 | - | May 03, 2023 | ||
| Illumina | 35.08B | 4.58B | -7.92 | 1.13 | -28.05 | - | Apr 25, 2023 | ||
| Incyte | 15.86B | 3.39B | 50.64 | 0.729 | 1.53 | - | May 02, 2023 | ||
| Ionis Pharma | 5.07B | 587.37M | -18.61 | 0.569 | -1.90 | - | May 03, 2023 | ||
| Mettler-Toledo | 33.02B | 3.92B | 38.43 | 1.18 | 38.79 | - | May 04, 2023 | ||
| Moderna | 57.39B | 19.26B | 6.99 | 1.70 | 21.22 | - | May 11, 2023 | ||
| Neurocrine | 9.38B | 1.49B | 60.24 | 0.484 | 1.61 | - | May 01, 2023 | ||
| Qiagen | 10.44B | 1.21B | 24.65 | 0.393 | 1.86 | - | May 02, 2023 | ||
| Regeneron Pharma | 87.45B | 12.17B | 20.32 | 0.244 | 40.51 | - | May 04, 2023 | ||
| Sarepta | 12.01B | 933.02M | -17.12 | 0.969 | -8.03 | - | May 03, 2023 | ||
| Seagen | 37.84B | 1.96B | -61.45 | 0.577 | -3.30 | - | Apr 27, 2023 | ||
| Ultragenyx | 2.74B | 363.33M | -3.86 | 0.959 | -10.12 | - | May 08, 2023 | ||
| United Therapeutics | 10.06B | 1.94B | 13.62 | 0.622 | 15.98 | - | May 03, 2023 | ||
| Vertex | 80.79B | 8.93B | 22.96 | 0.464 | 12.97 | - | May 03, 2023 |
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
